We also found that olmesartan, a selective AT1 receptor blocker (ARB), attenuated cardiac hypertrophy in TAC mice at least partially through down-regulation of CARP expression and consequently alleviating the accumulation of calcineurin. Here, AGTR1 is linked to cardiac hypertrophy.